Research / DT / Fundamental state Inspectable configuration
State dimensions Filing 0001773383-21-000083 General Corporate
Debt relative to revenue 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
172.79% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.41% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
39.80% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
34.87% · CORE · NOT_ENOUGH_HISTORY
Gross margin 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
81.49% · CORE · VALID
Operating margin 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
10.11% · CORE · VALID
R&D intensity 63th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.56% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
9.18% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 55.71%
Current 172.79%
Delta 117.08% Capex Intensity Decreased
Previous 2.00%
Current 1.41%
Delta -0.59% Cash Generation Increased
Previous 31.33%
Current 39.80%
Delta 8.46% Growth Increased
Previous 28.89%
Current 34.87%
Delta 5.98% Margin Decreased
Previous 81.85%
Current 81.49%
Delta -0.36% Profitability Decreased
Previous 13.06%
Current 10.11%
Delta -2.95% R And D Intensity Increased
Previous 15.84%
Current 16.56%
Delta 0.72% Sbc Intensity Increased
Previous 8.21%
Current 9.18%
Delta 0.97% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.